197 related articles for article (PubMed ID: 33958615)
1. Clinical characteristics of tumor lysis syndrome in childhood acute lymphoblastic leukemia.
Xue Y; Chen J; Gao S; Zhai X; Wang N; Gao J; Lv Y; Yin M; Zhuang Y; Zhang H; Zhu X; Wu X; Li CK; Hu S; Liang C; Jin R; Jiang H; Yang M; Sun L; Pan K; Cai J; Tang J; Guan X; Fang Y
Sci Rep; 2021 May; 11(1):9656. PubMed ID: 33958615
[TBL] [Abstract][Full Text] [Related]
2. Tumor Lysis Syndrome and Hyperleukocytosis in Childhood Acute Lymphoblastic Leukemia in a Tertiary Care Hospital.
Tasmeen R; Islam A; Alam ST; Begum M
Mymensingh Med J; 2017 Oct; 26(4):906-912. PubMed ID: 29208883
[TBL] [Abstract][Full Text] [Related]
3. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
Truong TH; Beyene J; Hitzler J; Abla O; Maloney AM; Weitzman S; Sung L
Cancer; 2007 Oct; 110(8):1832-9. PubMed ID: 17724682
[TBL] [Abstract][Full Text] [Related]
4. L-asparginase administration reduces white blood cell count and prevents tumor lysis syndrome in children with hyperleukocytic acute lymphoblastic leukemia.
Sondhi V; Sharma A; Taneja M; Arora B; Banavali SD
Acta Haematol; 2015; 133(1):6-9. PubMed ID: 24968963
[TBL] [Abstract][Full Text] [Related]
5. Pseudohyperkalemia accompanying actual hyperphosphatemia and hypocalcemia in an adolescent with T-lymphoblastic lymphoma.
Huang YC; Huang FL; Tsai SF; Jan SL; Fu LS
Clin Biochem; 2022 Mar; 101():5-8. PubMed ID: 34922929
[TBL] [Abstract][Full Text] [Related]
6. Clinical versus laboratory tumor lysis syndrome in children with acute leukemia.
Kedar A; Grow W; Neiberger RE
Pediatr Hematol Oncol; 1995; 12(2):129-34. PubMed ID: 7626380
[TBL] [Abstract][Full Text] [Related]
7. Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.
Saccente SL; Kohaut EC; Berkow RL
Pediatr Nephrol; 1995 Oct; 9(5):569-73. PubMed ID: 8580012
[TBL] [Abstract][Full Text] [Related]
8. The analysis of the risks for the development of tumour lysis syndrome in children.
Kopecna L; Dolezel Z; Osvaldova Z; Starha J; Hrstkova H
Bratisl Lek Listy; 2002; 103(6):206-9. PubMed ID: 12448566
[TBL] [Abstract][Full Text] [Related]
9. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
10. Tumor lysis syndrome in pediatric acute lymphoblastic leukemia at tertiary care center.
Naeem B; Moorani KN; Anjum M; Imam U
Pak J Med Sci; 2019; 35(4):899-904. PubMed ID: 31372114
[TBL] [Abstract][Full Text] [Related]
11. Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Réanimation Respiratoire et Onco-Hématologique.
Darmon M; Vincent F; Camous L; Canet E; Bonmati C; Braun T; Caillot D; Cornillon J; Dimicoli S; Etienne A; Galicier L; Garnier A; Girault S; Hunault-Berger M; Marolleau JP; Moreau P; Raffoux E; Recher C; Thiebaud A; Thieblemont C; Azoulay E;
Br J Haematol; 2013 Aug; 162(4):489-97. PubMed ID: 23772757
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
[No Abstract] [Full Text] [Related]
13. Laboratory and clinical features of tumor lysis syndrome in children with non-Hodgkin lymphoma and evaluation of long-term renal functions in survivors.
Bozkurt S; Genc DB; Vural S
BMC Pediatr; 2024 Jan; 24(1):85. PubMed ID: 38297237
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of tumor lysis syndrome in 380 cases of acute leukemia].
Zhang Q; Liu KQ; Liu BC; Zhou CL; Li W; Lin D; Wang Y; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):61-4. PubMed ID: 25687047
[TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome in children with non-Hodgkin lymphoma.
Alavi S; Arzanian MT; Abbasian MR; Ashena Z
Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415
[TBL] [Abstract][Full Text] [Related]
16. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model.
Montesinos P; Lorenzo I; Martín G; Sanz J; Pérez-Sirvent ML; Martínez D; Ortí G; Algarra L; Martínez J; Moscardó F; de la Rubia J; Jarque I; Sanz G; Sanz MA
Haematologica; 2008 Jan; 93(1):67-74. PubMed ID: 18166787
[TBL] [Abstract][Full Text] [Related]
17. Daily serum phosphate increase as early and reliable indicator of kidney injury in children with leukemia and lymphoma developing tumor lysis syndrome.
Biró E; Erdélyi D; Varga P; Sinkó M; Bartyik K; Kovács G; Ottóffy G; Vincze F; Szegedi I; Kiss C; Szabó T
Pediatr Nephrol; 2023 Sep; 38(9):3117-3127. PubMed ID: 36943467
[TBL] [Abstract][Full Text] [Related]
18. [Acute lymphoblastic leukemia complicated with tumor lysis syndrome--four cases report].
He H; Li C; Han M
Zhonghua Xue Ye Xue Za Zhi; 1999 Jun; 20(6):310-2. PubMed ID: 11721390
[TBL] [Abstract][Full Text] [Related]
19. Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).
Seftel MD; Bruyere H; Copland M; Hogge DE; Horsman DE; Nantel SH; Shepherd JD; Lavoie JC; Le A; Sutherland HJ; Toze CL; Nevill TJ
Eur J Haematol; 2002 Oct; 69(4):193-9. PubMed ID: 12431237
[TBL] [Abstract][Full Text] [Related]
20. Risk-based management strategy and outcomes of tumor lysis syndrome in children with leukemia/lymphoma: Analysis from a resource-limited setting.
Gopakumar KG; Seetharam S; Km JK; Nair M; Rajeswari B; Cs G; Vr P; Thankamony P
Pediatr Blood Cancer; 2018 Dec; 65(12):e27401. PubMed ID: 30101454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
